(Q44051825)

29 November 2017

title

Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study (English)

1 reference

29 November 2017

1 reference

A V Krymchantowski

1

1 reference

29 November 2017

J S Barbosa

series ordinal

2

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

22

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

309-312

1 reference

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

Oral lysine clonixinate in the acute treatment of migraine: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

Beyond monotherapy: rational polytherapy in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00369.X

10.1046/J.1468-2982.2002.00369.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference